ACLARION, INC. Revenue
ACLARION, INC. (ACON) reported Revenue of $25.21 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-06
- ACLARION, INC. revenues for the quarter ending 2026-06-30 was $25.21K, a 30.48% increase year-over-year.
- ACLARION, INC. revenues for the quarter ending 2026-03-31 was $21.14K, a 11.32% increase year-over-year.
- ACLARION, INC. revenues for the quarter ending 2025-12-31 was $18.48K, a 80.60% increase year-over-year.
- ACLARION, INC. revenues for the quarter ending 2025-09-30 was $18.94K, a 31.48% increase year-over-year.
- ACLARION, INC. revenues for fiscal 2025 was $75.73K, a 65.62% increase from fiscal 2024.
- ACLARION, INC. revenues for fiscal 2024 was $45.72K, a 39.36% decline from fiscal 2023.
- ACLARION, INC. revenues for fiscal 2023 was $75.40K, a 24.75% increase from fiscal 2022.
- ACLARION, INC. revenues for fiscal 2022 was $60.44K, a 0.25% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.21K 10-Q · filed 2026-08-06 | $46.35K 10-Q · filed 2026-08-06 | $64.83K derived: sum of 3 quarters · filed 2026-08-06 | $83.77K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $21.14K 10-Q · filed 2026-05-13 | $39.62K derived: sum of 2 quarters · filed 2026-05-13 | $58.56K derived: sum of 3 quarters · filed 2026-05-13 | $77.88K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $18.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $37.42K derived: sum of 2 quarters · filed 2026-03-18 | $56.74K derived: sum of 3 quarters · filed 2026-08-06 | $75.73K 10-K · filed 2026-03-18 |
| 2025-09-30 | $18.94K 10-Q · filed 2025-11-12 | $38.26K derived: sum of 2 quarters · filed 2026-08-06 | $57.25K 10-Q · filed 2025-11-12 | $67.48K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $19.32K 10-Q · filed 2026-08-06 | $38.31K 10-Q · filed 2026-08-06 | $48.54K derived: sum of 3 quarters · filed 2026-08-06 | $62.95K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.99K 10-Q · filed 2026-05-13 | $29.22K derived: sum of 2 quarters · filed 2026-05-13 | $43.63K derived: sum of 3 quarters · filed 2026-05-13 | $54.60K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $10.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $24.64K derived: sum of 2 quarters · filed 2026-03-18 | $35.61K derived: sum of 3 quarters · filed 2026-03-18 | $45.72K 10-K · filed 2026-03-18 |
| 2024-09-30 | $14.41K 10-Q · filed 2025-11-12 | $25.38K derived: sum of 2 quarters · filed 2025-11-12 | $35.49K 10-Q · filed 2025-11-12 | $49.29K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $10.97K 10-Q · filed 2025-08-14 | $21.09K 10-Q · filed 2025-08-14 | $34.88K derived: sum of 3 quarters · filed 2025-08-14 | $53.95K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $10.11K 10-Q · filed 2025-05-15 | $23.91K derived: sum of 2 quarters · filed 2025-05-15 | $42.98K derived: sum of 3 quarters · filed 2025-05-15 | $60.05K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $13.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $32.86K derived: sum of 2 quarters · filed 2025-04-09 | $49.93K derived: sum of 3 quarters · filed 2025-04-09 | $75.40K 10-K · filed 2025-04-09 |
| 2023-09-30 | $19.07K 10-Q · filed 2024-11-14 | $36.14K derived: sum of 2 quarters · filed 2024-11-14 | $61.61K 10-Q · filed 2024-11-14 | $84.13K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $17.07K 10-Q · filed 2024-08-14 | $42.54K 10-Q · filed 2024-08-14 | $65.06K derived: sum of 3 quarters · filed 2024-08-14 | $83.28K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $25.47K 10-Q · filed 2024-05-15 | $47.99K derived: sum of 2 quarters · filed 2024-05-15 | $66.21K derived: sum of 3 quarters · filed 2024-05-15 | $76.89K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $22.52K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $40.74K derived: sum of 2 quarters · filed 2024-03-28 | $51.42K derived: sum of 3 quarters · filed 2024-03-28 | $60.44K 10-K · filed 2024-03-28 |
| 2022-09-30 | $18.22K 10-Q · filed 2023-11-14 | $28.90K derived: sum of 2 quarters · filed 2023-11-14 | $37.92K 10-Q · filed 2023-11-14 | $49.90K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $10.68K 10-Q · filed 2023-08-25 | $19.70K 10-Q · filed 2023-08-25 | $31.68K derived: sum of 3 quarters · filed 2023-08-25 | $42.54K derived: sum of 4 quarters · filed 2023-08-25 |
| 2022-03-31 | $9.03K 10-Q · filed 2023-07-03 | $21.00K derived: sum of 2 quarters · filed 2023-07-03 | $31.87K derived: sum of 3 quarters · filed 2023-07-03 | $57.49K derived: sum of 4 quarters · filed 2023-07-03 |
| 2021-12-31 | $11.98K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $22.84K derived: sum of 2 quarters · filed 2023-06-12 | $48.46K derived: sum of 3 quarters · filed 2023-06-12 | $60.29K 10-K/A · filed 2023-06-12 |
| 2021-09-30 | $10.87K 10-Q · filed 2022-11-14 | $36.48K derived: sum of 2 quarters · filed 2022-11-14 | $48.31K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $25.62K 10-Q · filed 2022-08-15 | $37.45K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $11.83K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |